Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10888613 Method of producing cells resistant to HIV infection

Patent 10888613 was granted and assigned to American Gene Technologies on January, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

American Gene Technologies

Current Assignee

American Gene Technologies

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Charles David Pauza0

Haishan Li0

Tyler Lahusen0

Date of Patent

January 12, 2021

Patent Application Number

16076655

Date Filed

January 11, 2017

Patent Citations

US Patent 10208295 MRNA therapy for phenylketonuria

0

US Patent 10023880 Methods and compositions for the activation of gamma-delta T-cells

US Patent 10036038 HIV pre-immunization and immunotherapy

0

US Patent 10036040 Methods and compositions for the activation of gamma-delta T-cells

US Patent 10137144 Methods and compositions for the activation of gamma-delta T-cells

US Patent 10233464 HIV pre-immunization and immunotherapy

0

Patent Citations Received

US Patent 11911458 HIV pre-immunization and immunotherapy

0

Patent Primary Examiner

Nicole Kinsey White

Patent abstract

The present invention relates generally to immunotherapy for preventing HIV infection in HIV-negative individuals. In particular, the methods include in vivo and/or ex vivo enrichment of HIV-specific CD4+ T cells.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10888613 Method of producing cells resistant to HIV infection

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool